Open Now
Contact Information
2 1/2 Beacon Street Suite 449, Concord, New Hampshire 3301, United States
Detailed Information
PursueCare LLC
-
Services:
- Screening for tobacco use
- Complete medical history/physical exam
- Interim services for clients
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Screening for mental disorders
- Outreach to persons in the community
- Screening for substance use
- Mental health services
- Case management service
- Suicide prevention services
- Smoking permitted in designated area
- Medicaid
- Medicare
- Federal military insurance (e.g., TRICARE)
- Private health insurance
- State-financed health insurance plan other than Medicaid
- Cash or self-payment
- Prescribes naltrexone
- Relapse prevention with naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Prescribes buprenorphine
- Buprenorphine maintenance
- The Joint Commission
- State Substance use treatment agency
- Adult women
- Pregnant/postpartum women
- Adult men
- Clients who have experienced trauma
- Trauma-related counseling
- Matrix Model
- Telemedicine/telehealth therapy
- Substance use disorder counseling
- Motivational interviewing
- Relapse prevention
- Contingency management/motivational incentives
- Anger management
- Cognitive behavioral therapy
- Brief intervention
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Assistance with obtaining social services
- Mentoring/peer support
- Self-help groups
- Housing services
- Vaping permitted in designated area
- Adults
- Young Adults
- No formal relationship with prescribing entity
- Other contracted prescribing entity
- In-network prescribing entity
- Discharge Planning
- Aftercare/continuing care
- Outcome follow-up after discharge
- Naloxone and overdose education
- Outpatient
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Naltrexone (oral)
- Clonidine
- Buprenorphine with naloxone
- Medication for mental disorders
- Naltrexone (extended-release, injectable)
- Acamprosate (CampralĀ®)
- Buprenorphine without naloxone
- Disulfiram
- Non-nicotine smoking/tobacco cessation
- Nicotine replacement
- Female
- Male
- Drug and alcohol oral fluid testing
- Drug or alcohol urine screening
- This facility administers/prescribes medication for alcohol use disorder
- Hepatitis education, counseling, or support
- Family counseling
- Substance use disorder education
- Group counseling
- Smoking/vaping/tobacco cessation counseling
- HIV or AIDS education, counseling, or support
- Individual counseling
- Sliding fee scale (fee is based on income and other factors)
- Private for-profit organization
- Sign language services for the deaf and hard of hearing
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
Assessment/Pre-treatment
Ancillary Services
Facility Smoking Policy
Payment/Insurance/Funding Accepted
Type of Opioid Treatment
License/Certification/Accreditation
Special Programs/Groups Offered
Treatment Approaches
Opioid Medications used in Treatment
Recovery Support Services
Facility Vaping Policy
Age Groups Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
Transitional Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Pharmacotherapies
Gender Accepted
Testing
Type of Alcohol Use Disorder Treatment
Education and Counseling Services
Payment Assistance Available
Facility Operation (e.g., Private, Public)
Language Services
Type of Care
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm